Comparative analysis of red mud reduction techniques was performed using both carbothermal and hydrogen-based reduction methods, combining thermochemical modeling and experimental validation. The reduction process is mostly important because of the high contamination risk assessment of soil with disposed red mud. Therefore, the minimization of red mud during the reduction process can be a novel strategy for the production of metallic iron and solid residue for hydrometallurgical treatment. Different strategies of hydrogen and carbon reduction in static and dynamic conditions were studied between 700 °C and 1700 °C. The separation of solid residue and formed iron was analyzed using magnetic separation. The main aim was to study the advantages and disadvantages of using decarbonizing technologies for the treatment of red mud, aiming to develop an environmentally friendly process. Thermochemical analysis of the reduction offered new data about mass losses during our process through the evaporation, thermal decomposition, and formation of metallic carbide.

Biodentine, a tricalcium silicate cement, has emerged as a retrograde root-end filling material to promote periapical lesion (PL) healing after apicoectomy. However, its underlying mechanisms remain unclear. This study tested the hypothesis that Biodentine stimulates the osteogenic differentiation of mesenchymal stromal cells (MSCs) derived from PLs. The Biodentine extract (B-Ex) was prepared by incubating polymerized Biodentine in RPMI medium (0.2 g/mL) for three days at 37 °C. B-Ex, containing both released microparticles and soluble components, was incubated with PL-MSCs cultured in either a basal MSC medium or suboptimal osteogenic medium. Osteogenic differentiation was assessed by Alizarin Red staining and the expression of 20 osteoblastogenesis-related genes. Non-cytotoxic concentrations of B-Ex stimulated the proliferation of PL-MSCs and induced their osteogenic differentiation in a dose-dependent manner, with a significantly enhanced effect in suboptimal osteogenic medium. B-Ex upregulated most early and late osteoblastic genes. However, the differentiation process was prolonged, as indicated by the delayed expression of wingless-type MMTV integration site family member 2 (WNT2), bone gamma-carboxyglutamate protein (BGLAP), bone morphogenic protein-2 (BMP-2), growth hormone receptor (GHR), and FOS-like 2, AP-1 transcription factor subunit (FOSL2), compared with their expression under optimal osteogenic conditions. The stimulatory effect of B-Ex was primarily calcium dependent, as it was reduced by 85% when B-Ex was treated with the calcium-chelating agent EGTA. In conclusion, Biodentine promotes the osteogenic differentiation of PL-MSCs in a calcium-dependent manner, supporting its stimulatory role in periapical healing.

INTRODUCTION Acute bacterial meningitis (ABM) is a serious infectious disease and medical emergency. Given the fact of its high mortality and morbidity, detecting prognostic factors is potentially useful in improving treatment strategies. This paper aims to determine prognostic factors of short-term outcomes of patients with ABM in a developing country - Bosnia and Herzegovina, measured by the Modified Rankin Scale (MRS) at discharge. METHODOLOGY In this retrospective cohort study, 56 patients treated at the Clinic of Infectious Diseases, Clinical Center University of Sarajevo, for 11 years (2012-2022) were included. Statistical analysis was performed using IBM SPSS Statistics version 29.0.1.0. RESULTS The subjects' average age was 31.6 ± 27.7 years, with the youngest patient being 4 months and the oldest 75 years old. Among those, 31 were male and 25 were female. Unfavorable outcomes had 16 (28.6%) patients, including fatal outcomes in four patients and severe disabilities in 12 patients (MRS: 2-6), while 40 (71.4%) patients had favorable outcomes (MRS: 0-1). In the multivariate analysis, predictors of unfavorable outcomes included age older than 60 years, duration of symptoms longer than 24 hours, presence of neurological defects at admission, impaired consciousness, respiratory distress, and no corticosteroid use during treatment. CONCLUSIONS There is certainly a window of opportunity for patients with ABM: The shorter the time between disease onset and treatment initiation, the better the disease outcome.

Background and Objectives More than half of the endovascularly treated ischemic stroke patients with incomplete reperfusion (expanded Thrombolysis in Cerebral Infarction [eTICI] <3) show delayed reperfusion (DR) on 24-hour perfusion imaging, which is associated with favorable clinical outcome. The effect of intravenous thrombolysis (IVT) on the rates of DR remains unclear. This study aimed to assess the treatment effect of IVT on the occurrence of DR. Methods Pooled data from 3 randomized controlled trials (EXTEND-IA and EXTEND-IA TNK parts 1 and 2) and 2 comprehensive stroke centers (University Hospitals Graz and Bern) were analyzed. Only patients with a final reperfusion score of eTICI 2a-2c and available perfusion imaging at follow-up of 24 ± 12 hours were included. The primary outcome was the presence of DR on 24-hour follow-up CT/MRI perfusion imaging, defined as the absence of any focal perfusion deficit on perfusion imaging, despite incomplete reperfusion on the final angiography series during thrombectomy. For the secondary analysis, we explored the association between the primary outcome (DR) and the time elapsed between start of IVT and the end of an intervention. To address confounding in observational data, we performed a target trial emulation. Results Of 832 included patients with eTICI 2a-2c (median age 74 years, 49% female), 511 (61%) had DR. There was an independent treatment effect of IVT on DR (standardized risk ratio [sRR] 1.1, 95% CI 1.0–1.3; standardized risk difference [sRD] 8.2%, 95% CI 0.2%–16.1%), after adjusting for age, sex, atrial fibrillation, number of device passes, collateral score, and eTICI. Among those patients who have received IVT (n = 524/832, 63%), when adjusting for the aforementioned covariates, there was a causal effect of shorter time between administration of thrombolytics and end of the intervention on DR (sRR 0.93%, 95% CI 0.87–0.98; sRD −5.2%; 95% CI −9.1% to −1.3%, per hour increase). Discussion Exposure to thrombolytics showed independent treatment effect on the occurrence of DR among patients with incomplete reperfusion after thrombectomy who undergo perfusion imaging at the 24-hour follow-up. The effect of thrombolytics on DR was observed if there was a high chance of therapeutic concentrations of thrombolytics at the time point when the proximal vessel was recanalized, but distal occlusions persisted and/or occurred. Classification of Evidence This study is rated Class III because it is a nonrandomized study and there are substantial differences in baseline characteristics of the treatment groups.

Introduction: Sensory integration is the way in which the nervous system processes information from the senses. Irregularities or disturbances in brain function that make it difficult to integrate sensory input from stimuli lead to sensory disintegration. The proprioceptive sensory system provides information about joint and body movements, extent, strength, duration and direction of movement, position of the body or body parts in space, and muscle tone. The aim of this study is to investigate the prevalence of sensory integration disorders of the proprioceptive sensory system in children with intellectual disabilities and children without developmental disabilities and to determine whether the existing difference is statistically significant. Methods: The study was conducted on a sample of 60 respondents. The first subsample of respondents (n = 30) consisted of children with intellectual disabilities. The second subsample of respondents (n = 30) consisted of children without developmental disabilities of the same chronological age. The measuring instrument “Questionnaire for examining proprioceptive sensory sensitivity” was used. Data were collected by observing the respondents and interviewing the rehabilitator and the child’s parents. The frequencies and percentages of the respondents’ answers for all variables were calculated. To determine the statistical significance of differences, the Mann-Whitney U test and Wilcoxon W test were used at a statistical significance level of p < 0.05. Results: The results show that 81.4% of children with intellectual disabilities have difficulties with sensory integration of the sensations of the proprioceptive sensory system, manifested as hypersensitivity (37.6%), hyposensitivity (19.5%), and mixed sensory response (24.3%). Sensory integration difficulties are also experienced by 75.7% of children without developmental disabilities, manifested by hypersensitivity (17.62%), hyposensitivity (27.6%), and mixed sensory reactions (30.5%). There is a statistically significant difference in the variables: high-risk games, fine motor tasks, and activities requiring physical strength. For the other variables, the difference in sensory integration is not statistically significant. Conclusion: 81.4% of children with intellectual disabilities and 75.7% of children without developmental disabilities have difficulties in sensory integration of the proprioceptive sensory system. Children with intellectual disabilities show better integration of proprioceptive sensory input in activities requiring physical strength and in activities with eyes closed or covered. In all other activities, they show poorer sensory integration of proprioceptive sensations than children without developmental disabilities.

Origanum compactum, Melaleuca alternifolia, and Cinnamomum camphora essential oils are recognized for their therapeutic potential, including their selective cytotoxicity against cancer cell lines. Our research focused on examining the cytotoxic effects of these essential oils on three human carcinoma cell lines: lung carcinoma (H460), cervical adenocarcinoma (HeLa), and colorectal carcinoma (HCT116). The MTT-based cell viability assay was used to assess the cytotoxicity of essential oils. The results demonstrated that all three essential oils exhibited dose-dependent cytotoxic potential, with varying levels of growth inhibition across the cell lines. Notably, the highest sensitivity was observed in H460 cells, and the lowest sensitivity was found in HCT116 cells. Origanum compactum demonstrated the strongest cytotoxicity across all cell lines (GI50 73 - 154 nL/mL), making it the most promising candidate for further investigation, particularly for lung and cervical cancer treatment.

ABSTRACT Background Newly or already diagnosed cancer might significantly influence the clinical presentation, outcome, and therapy of acute pulmonary embolism (PE). Methods Out of 1745 patients with acute PE, 66 patients were diagnosed with cancer during an initial hospitalization due to acute PE (where PE was the first clinical manifestation of cancer), 165 patients had known cancer treated in the last 6 months, and 1514 patients had acute PE without known or suspected cancer. The primary end‐point of the present study was all‐cause hospital death. The secondary end‐points were the proportion of patients treated with thrombolysis and who had severe disease, and the ocurrence of major or clinically relevant nonmajor bleeding. Results Patients with PE as the first presentation of cancer had the highest hospital mortality rate compared to the other two groups (HR for the mortality rate in patients without cancer as a reference, adjusted to four‐stratum mortality risk, and Charlson's comorbidity index was 3.440; 95% confidence interval (CI), 1.795–6.591; p < 0.001). Patients with known cancer before PE had a significantly lower chance of being treated with thrombolysis than patients without cancer (OR, 0.523; 95% CI, 0.339–0.807; p = 0.003); additionally, this difference was attenuated but remained when the OR was adjusted to age (OR, 0.542; 95% CI, 0.351–0.838; p = 0.006). Patients with known cancer had a higher frequency of high‐risk PE compared with patients without cancer (18.2% vs. 12.8%; p < 0.001). Patients with PE as the first manifestation of cancer had a higher frequency of intermediate‐high‐risk PE than those without (36.4% vs. 30.9%; p < 0.001). There was no significant difference in bleeding during hospitalization between groups. Conclusion Patients with cancer had a more severe presentation of acute PE than patients without. Furthermore, patients with PE as the first manifestation of cancer had the highest hospital mortality rate, and patients with known cancer were least likely to be treated with thrombolysis.